News Releases
Scientists Unlock Key to Tamoxifen Resistance
23 February 2010
Cancer Research UK funded scientists have discovered why some breast cancers are resistant to the commonly used drug tamoxifen, their findings are published in Cancer Research today (23 February).
Read more...
23 February 2010
New research suggests that methods recently developed for the molecular classification of breast cancer may be unsuitable for selecting patients for clinical trials.
Read more...
New Drug Benefits Late-Stage Prostate Cancer Patients
16 February 2010
The prostate cancer drug abiraterone shows encouraging results in men who have exhausted standard treatment options, according to clinical trial results published online today in the Journal of Clinical Oncology.
Read more...
Lower Overall Dosage of Radiotherapy in Fewer Larger Doses as Safe for Breast Cancer Patients
8 February 2010
The chronic side-effects of radiotherapy for early breast cancer, as reported by women themselves, are not any worse when treatment is given in a lower overall dose in fewer but larger treatments according to a trial part funded by Cancer Research UK and published today in the Lancet Oncology.
Read more...
The Institute of Cancer Research Receives Environmental Honour
3 February 2010
The Institute of Cancer Research (ICR) is pleased to announce that it will be presented with the EcoCampus Bronze Certificate on 3rd February in recognition of its commitment to improve environmental sustainability.
Read more...
Genetic Abnormalities Predict Prostate Cancer Survival
27 January 2010
Researchers have discovered that the combination of three genetic abnormalities significantly impacts how long a prostate cancer patient is likely to survive with the disease, according to the latest edition of the British Journal of Cancer.
Read more...
26 January 2010
SGI (NASDAQ: SGI), a global leader in HPC and data centre solutions, today announced that The Institute of Cancer Research (ICR) has selected SGI® Altix® UV, based on Intel® Xeon® processors (codenamed Nehalem-EX), to support its future life-saving research.
Read more...
Surprising Discovery Could Help Scientists Refine Treatment for Advanced Melanoma
21 January 2010
A team of UK scientists has made the unexpected discovery that drugs which target a well known fault in a protein called BRAF could actually fuel the progression of cancer in some cases. The findings of this study, which was jointly funded by Cancer Research UK, The Institute of Cancer Research (ICR) and the Wellcome Trust are published in Cell.
Read more...
New Molecules Increase the Effectiveness of Certain Cancer Therapies
20 January 2010
Scientists at The Institute of Cancer Research (ICR) and Sareum have developed novel chemical compounds that increase the effectiveness of current cancer therapeutics, an example of which is published in the latest edition of the journal Molecular Cancer Therapeutics.
Read more...
